Skip to main content Skip to navigation

banner

Introduction

Our researchers regularly undertake evidence synthesis on a range of available evidence to determine the clinical and cost effectiveness of technologies and drugs.

Warwick Evidence

evidence

Warwick Evidence undertakes evidence synthesis (e.g. meta-analysis, NMA, meta synthesis, qualitative synthesis) on a range of available evidence to determine the clinical and cost effectiveness of technologies and drugs. Examples of our projects can be found here.

Health Economics

economics

Members of the Centre participate in evidence synthesis (e.g. meta-analysis, NMA, meta synthesis, qualitative synthesis) and use its results to determine the clinical and cost effectiveness of technologies and drugs.

Communicable Disease Control Evidence and Epidemiology (CDCE²)

cdce2

Recent work in this area by the CDCE² group includes a systematic review of community onset sepsis and the effectiveness of treatments for pneumococcal infections.

Collaboration for Leadership in Applied Health Research and Care West Midlands (CLAHRC)

clahrc

Collaboration for Leadership in Applied Health Research and Care West Midlands (CLAHRC) is involved in evidence synthesis through Theme 3, ‘Prevention and detection of diseases’. An example of projects in this area are systematic reviewing, Cochrane reviews, national screening committee evidence reviews and network meta-analyses.

Warwick Research In Nursing

wrn

Warwick Research In Nursing has undertaken or contributed to a number of evidence syntheses studies, including

- GRIPP 2: Developing consensus on guidance for reporting patient and public involvement.

-EURIPIDES- Evaluating the use of patient experience data to improve the quality of inpatient mental health care.

Statistics and Epidemiology

stats

The Statistics and Epidemiology group are involved in a number of Cochrane reviews, particularly those looking at the effects of non-pharmacological interventions for the prevention and management of cardiovascular disease.